✦ LIBER ✦

Mitoxantrone: benefits and risks in multiple sclerosis patients

✍ Scribed by V. Martinelli; M. Radaelli; L. Straffi; M. Rodegher; G. Comi

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Autologous haematopoietic stem-cell tran

✍ E. Capello; L. Vuolo; F. Gualandi; M. T. Van Lint; L. Roccatagliata; L. Bonzano; 📂 Article 📅 2009 🏛 Springer Milan 🌐 English ⚖ 120 KB

Cyclophosphamide as second-line therapy

✍ Luciano Rinaldi; P. Perini; M. Calabrese; P. Gallo 📂 Article 📅 2009 🏛 Springer Milan 🌐 English ⚖ 137 KB

Multiple sclerosis patients—benefit-risk

✍ F. Reed Johnson; George Van Houtven; Semra Özdemir; Steve Hass; Jeff White; Gord 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 269 KB

Suppression of mitoxantrone cardiotoxici

✍ Evanthia Bernitsas; Wei Wei; Daniel D. Mikol 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 68 KB

Acute myeloid leukaemia induced by mitox

✍ Radu Tanasescu; Marc Debouverie; Sophie Pittion; Rene Anxionnat; Herve Vespignan 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 113 KB

Mitoxantrone versus cyclophosphamide in

✍ Paola Perini; Massimiliano Calabrese; Michela Tiberio; Federica Ranzato; Leontin 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 133 KB